Polymorphism of costimulatory molecules (CTLA4, ICOS, PD.1 and CD28) and allogeneic hematopoietic stem cell transplantation in Iranian patients

References

• Azarian M, Busson M, Lepage V, et al. (2007). Donor CTLA-4 +49 A/G*GG genotype is associated with chronic GVHD after HLA-identical hematopoietic stem-cell transplantations. Blood, 110, 4623–4
   PubMed Web of Science ®Google Scholar
• Bleakley M, Ridell SR. (2004). Molecules and mechanisms of the graft-versus leukemia effect. Nat Rev Cancer, 5, 371–80
   Google Scholar
• Castelli L, Comi C, Chiocchetti A, et al. (2007). ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution. J Neuro Immunol, 186, 193–8
   Google Scholar
• Chen L. (2004). Co-inhibitory molecules of the B7-CD28 family in the control of T cell immunity. Nat Rev Immunol, 4, 336–47
   PubMed Web of Science ®Google Scholar
• Cunninghame Graham DS, Wong AK, McHugh NJ, et al. (2006). Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet, 15, 3195–205
   Google Scholar
• De Reuver P, Pravica V, Hop W, et al. (2003). Recipient CTLA-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation. Am J Transplant, 3, 1587–94
   Google Scholar
• Dickinson AM, Charron D. (2005). Non-HLA immunogenetics in hematopoietic stem cell transplantation. Curr Opin Immunol, 7, 517–25
   Google Scholar
• Dickinson AM, Harrold JL, Cullup H. (2007). Hematopoietic stem cell transplantation: Can our genes predict clinical outcome. Expert Rev Mol Med, 9, 1–19
   PubMedGoogle Scholar
• Dickinson AM, Middleton PG. (2005). Beyond the HLA typing age: Genetic polymorphisms predicting transplant outcome. Blood Rev, 19, 333–40
   PubMed Web of Science ®Google Scholar
• Dickinson AM, Middleton PG, Rocha V, et al. (2004). Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol, 127(5), 479–90
   Google Scholar
• Dilmec F, Ozgonul A, Uzunkoy A, Akkafa F. (2008). Investigation of CTLA4 andCD28gene polymorphisms in a group of Turkish patients with colorectal cancer. Int J Immunogenet, 35, 317–21
   Google Scholar
• Evans A, Riva A, Cooksley H, et al. (2008). Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen sero conversion. Hepatol, 48, 759–69
   PubMed Web of Science ®Google Scholar
• Finger LR, Pu J, Wasserman R, et al. (1997). The human PD-1 gene: Complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene, 197, 177–87
   PubMed Web of Science ®Google Scholar
• Freeman GJ, Long AJ, Iwai Y, et al. (2000). Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med, 192, 1027–34
   PubMed Web of Science ®Google Scholar
• Gallez-Hawkins GM, Thao L, Palmer J, et al. (2009). Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant, 15, 872–80
   Google Scholar
• Glucksberg H, Storb R, Fefer A, et al. (1974). Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295–304
   PubMed Web of Science ®Google Scholar
• Guo L, Li XK, Funeshima N, et al. (2002). Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation, 1573, 1027–32
   Google Scholar
• Haimila K, Smedberg T, Mustalahti K, et al. (2004). Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun, 5, 85–92
   PubMed Web of Science ®Google Scholar
• Hansen JA, Petersdorf EW, Lin MT, et al. (2008). Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes. Immunol Res, 41, 56–78
   Google Scholar
• Harada H, Salama AD, Sho M, et al. (2003). The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity. J Clin Invest, 112, 234–43
   PubMed Web of Science ®Google Scholar
• Inman BA, Frigola X, Dong H, Kwon ED. (2007). Costimulation, coinhibition and cancer. Curr Cancer Drug Targets, 7, 15–30
   PubMed Web of Science ®Google Scholar
• Karimi MH, Motazedian M, Geramizadeh B, et al. (2011). Association of the costimulatory molecules polymorphisms with CMV Infection in liver transplant recipients. Int J Organ Transplant Med, 2, 171–7
   Google Scholar
• Karimi MH, Motazedian M, Abedi F, et al. (2012). Association of genetic variation in co-stimulatory molecule genes with outcome of liver transplant in Iranian patients. Gene, 504, 127–32
   Google Scholar
• Keir ME, Liang SC, Guleria I, et al. (2006). Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med, 203, 883–95
   PubMed Web of Science ®Google Scholar
• Kouki T, Sawai Y, Gardine CA, et al. (2000). CTLA-4 gene polymorphism at position 49 in exon1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol, 165, 6606–11
   PubMed Web of Science ®Google Scholar
• Krichen H, Sfar I, Jendoubi-Ayed S, et al. (2009). Genetic polymorphisms of immunoregulatory proteins in acute renal allograft rejection. Transplant Proc, 41, 3305–7
   Google Scholar
• Kroner A, Mehling M, Hemmer B, et al. (2005). A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol, 58, 50–7
   PubMed Web of Science ®Google Scholar
• Liu X, Hu LH, Li YR, et al. (2011). Programmed cell death 1 gene polymorphisms are associated with ankylosing spondylitis in Chinese Han population. Rheumatol Int, 31, 209–13
   PubMed Web of Science ®Google Scholar
• Marder BA, Schröppel B, Lin M, et al. (2003). The impact of costimulatory molecule gene polymorphisms on clinical outcomes in liver transplantation. Am J Transplant, 3(4), 424–31
   Google Scholar
• Marín LA, Moya-Quiles MR, Miras M, et al. (2005). Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients. Transplant Immunol, 15, 69–74
   PubMed Web of Science ®Google Scholar
• Monne M, Piras G, Palmas A, et al. (2004). Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma. Am J Hematol, 76, 14–8
   PubMed Web of Science ®Google Scholar
• Morita M, Fujino M, Jiang G, et al. (2010). PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft. Am J Transplant, 10, 40–6
   PubMed Web of Science ®Google Scholar
• Pérez-García A, De la Cámara R, Román-Gómez J, et al. (2007). CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood, 110, 461–7
   PubMed Web of Science ®Google Scholar
• Reddy P, Ferrara JL. (2003). Immunobiology of acute graft versus-host disease. Blood Rev, 17, 187–94
   PubMed Web of Science ®Google Scholar
• Rowlings PA, Przepiorka D, Klein JP, et al. (1997). IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br J Haematol, 97, 855–64
   PubMed Web of Science ®Google Scholar
• Rueda B, Zhernakova A, López-Nevot MA, et al. (2005). CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders. Hum Immunol, 66, 321–5
   Google Scholar
• Salomon B, Bluestone JA. (2001). Complexities of CD28/B7: CTLA4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol, 19, 225–52
   PubMed Web of Science ®Google Scholar
• Scandiuzzi L, GhoSh K, Zang X. (2011). T Cell costimulation and coinhibition: Genetics and disease. Discov Med, 12, 119–28
   Google Scholar
• Schuchmann M, Meyer RG, Distler E, et al. (2008). The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation. Am J Transplant, 8, 2434–44
   Google Scholar
• Soleimanifar N, Amirzargar AA, Mahmoudi M, et al. (2011). Study of programmed cell death 1 (PDCD1) gene polymorphims in Iranian patients with ankylosing spondylitis, 34, 707–12
   Google Scholar
• Sperling AI, Bluestone JA. (1996). The complexities of T-cell costimulation: CD28 and beyond. Immunol Rev, 153, 155–82
   PubMedGoogle Scholar
• Spierings E, Wieles B, Goulmy E. (2004). Minor histocompatibility antigens–big in tumour therapy. Trends Immunol, 25, 56–60
   PubMed Web of Science ®Google Scholar
• Tanaka K, Albin MJ, Yuan X, et al. (2007). PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J Immunol, 179, 5204–10
   PubMed Web of Science ®Google Scholar
• Taylor PA, Panoskaltsis-Mortari A, Freeman GJ, et al. (2005). Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM). Blood, 105, 3372–80
   PubMed Web of Science ®Google Scholar
• Thomas ED, Storb R, Clift RA, et al. (1975). Bone-marrow transplantation. N Engl J Med, 292, 895–902
   PubMed Web of Science ®Google Scholar
• Torres B, Aguilar F, Franco E, et al. (2004). Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum, 50, 2211–5
   PubMed Web of Science ®Google Scholar
• Ueda H, Howson JM, Esposito L, et al. (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 423, 506–11
   PubMed Web of Science ®Google Scholar
• Velázquez-Cruz R, Orozco L, Espinosa-Rosales F, et al. (2007). Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus. Eur J Hum Genet, 15, 336–41
   PubMed Web of Science ®Google Scholar
• Vidal-Castiñeira JR, López-Vázquez A, Alonso-Arias R, et al. (2012). A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping. J Hepatol, 56, 1230–8
   Google Scholar
• Wang L, Han R, Hancock WW. (2007a). Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Eur J Immunol, 37, 2983–90
   Google Scholar
• Wang L, Li D, Fu Z, et al. (2007b). Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer, 10, 173
   Google Scholar
• Wang Q, Ye D, Yin J, et al. (2008). Programmed cell death 1 genotypes are associated with susceptibility to systemic lupus erythematosus among Chinese. Arch Dermatol Res, 300, 91–3
   PubMed Web of Science ®Google Scholar
• Wang SC, Chen YJ, Ou TT, et al. (2006). Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan. J Clin Immunol, 26, 506–11
   PubMed Web of Science ®Google Scholar
• Wiśniewski A, Kusztal M, Magott-Procelewska M, et al. (2006). Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant. Transplant Proc, 38, 56–8
   PubMed Web of Science ®Google Scholar
• Wu J, Tang JL, Wu SJ, et al. (2009). Functional polymorphism of CTLLA4 and ICOS genes in allogeneic hematopoietic stem cell transplantation. Clin Chim Acta, 403, 229–33
   PubMed Web of Science ®Google Scholar
• Yaghobi R, Iravani-Saadi M, Karimi MH, et al. (2013). Study the relationship between costimulatory moleculespolymorphism and the hepatitis B infection in hematopoietic stem celltransplant recipients. Exp Clin Transplant. 2013 [Epub ahead of print]
   Google Scholar
• Yousefipour G, Erfani N, Momtahan M, et al. (2009). CTLA4 exon1 and promoter polymorphisms in patients with multiple sclerosis. Acta Neurol Scand, 120, 424–9
   PubMed Web of Science ®Google Scholar
• Yu XZ, Liang Y, Nurieva RI, et al. (2006). Opposing effects of ICOS on Graft Versus-Host Disease mediated by CD4 and CD8 T cells. J Immunol, 176, 7394–401
   Google Scholar
• Zhang G, Li Z, Han Q, et al. (2011). Altered TNF-α and IFN-γ levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection. Infect Genet Evol, 11, 1624–30
   Google Scholar